Jasmeet Kaur Selected Research

1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)

9/2011	Diclofenac, a selective COX-2 inhibitor, inhibits DMH-induced colon tumorigenesis through suppression of MCP-1, MIP-1α and VEGF.
7/2011	Intracellular pH and calcium signaling as molecular targets of diclofenac-induced apoptosis against colon cancer.
12/2010	PI3-kinase/Wnt association mediates COX-2/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: chemoprevention by diclofenac.
9/2010	Modulation of inflammatory changes in early stages of colon cancer through activation of PPARgamma by diclofenac.
8/2010	Alterations in membrane fluidity and dynamics in experimental colon cancer and its chemoprevention by diclofenac.
1/2010	Intrinsic mitochondrial membrane potential change and associated events mediate apoptosis in chemopreventive effect of diclofenac in colon cancer.
1/2010	Induction of apoptosis as a potential chemopreventive effect of dual cycloxygenase inhibitor, diclofenac, in early colon carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jasmeet Kaur Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 01/2009
8	Colonic Neoplasms (Colon Cancer) 09/2011 - 01/2009
5	Carcinogenesis 09/2011 - 01/2009
4	COVID-19 07/2022 - 01/2021
3	Body Weight (Weight, Body) 09/2011 - 02/2010
2	Thrombosis (Thrombus) 02/2022 - 01/2022
2	Infections 01/2022 - 04/2012
2	Heart Failure 08/2021 - 07/2021
2	Neoplasm Metastasis (Metastasis) 07/2021 - 01/2021
2	Lipoid congenital adrenal hyperplasia 01/2017 - 01/2016
1	Pulmonary Embolism 02/2022
1	Thrombophilia 01/2022
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Vitamin D Deficiency 01/2022
1	Thromboembolism 01/2022
1	Renal Insufficiency (Renal Failure) 08/2021
1	Thrombocytopenia (Thrombopenia) 08/2021
1	Autoimmune Diseases (Autoimmune Disease) 08/2021
1	ST Elevation Myocardial Infarction 07/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2021
1	Spinal Cord Compression 07/2021
1	Disease Progression 07/2021
1	Myocardial Infarction 07/2021
1	Febrile Neutropenia 05/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Dyspnea (Shortness of Breath) 01/2021
1	Anemia 01/2021
1	Pathologic Complete Response 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Lipidoses 01/2021
1	Adenocarcinoma 01/2021
1	Carcinoma (Carcinomatosis) 11/2020
1	Gangrene 10/2017
1	Sclerosis 10/2017
1	Disorders of Sex Development (Intersexuality) 01/2017
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2016
1	Stillbirth 01/2016
1	Mucopolysaccharidosis II (Hunter Syndrome) 04/2012
1	Mucopolysaccharidoses 04/2012
1	Inguinal Hernia (Direct Inguinal Hernia) 04/2012

Drug/Important Bio-Agent (IBA)

8	Diclofenac (SR 38)FDA LinkGeneric 12/2011 - 01/2010
8	Dimenhydrinate (DMH)FDA LinkGeneric 09/2011 - 01/2009
7	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 09/2011 - 01/2010
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2011 - 01/2010
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2011 - 01/2009
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2011 - 01/2009
2	RNA (Ribonucleic Acid)IBA 01/2021 - 04/2012
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 11/2020
2	SaltsIBA 01/2017 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2014
2	EnzymesIBA 01/2016 - 04/2012
1	Immunoglobulins (Immunoglobulin)IBA 07/2022
1	VaccinesIBA 07/2022
1	Antiphospholipid AntibodiesIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 08/2021
1	omega-Chloroacetophenone (Mace)IBA 07/2021
1	TeicoplaninIBA 05/2021
1	Vancomycin FDA LinkGeneric 05/2021
1	cold agglutininsIBA 01/2021
1	AgglutininsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	erucic acidIBA 01/2021
1	Taxoids (Taxanes)IBA 11/2020
1	Fluorouracil (Carac)FDA LinkGeneric 11/2020
1	Methotrexate (Mexate)FDA LinkGeneric 10/2017
1	SteroidsIBA 10/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2016
1	steroidogenic acute regulatory proteinIBA 01/2016
1	CholesterolIBA 01/2016
1	Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA 01/2016
1	PregnenoloneIBA 01/2016
1	Aromatase (CYP19)IBA 02/2014
1	GlycosaminoglycansIBA 04/2012
1	Anesthetics (Anesthetic Agents)IBA 04/2012
1	Celecoxib (Celebrex)FDA Link 12/2011
1	Apoptosomes (Apoptosome)IBA 12/2011
1	Apoptosis Regulatory ProteinsIBA 12/2011

Therapy/Procedure

9	Therapeutics 04/2022 - 06/2011
7	Chemoprevention 09/2011 - 01/2010
2	Radiotherapy 07/2021 - 11/2020
2	Drug Therapy (Chemotherapy) 01/2021 - 11/2020
1	Catheters 02/2022
1	Defibrillators (Defibrillator) 02/2022
1	Decompression 07/2021
1	Kyphoplasty 07/2021
1	Percutaneous Coronary Intervention 07/2021
1	Ischemic Postconditioning 07/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Length of Stay 01/2021
1	Cystectomy 01/2021
1	Immunotherapy 01/2021
1	Neoadjuvant Therapy 01/2021
1	Chemoradiotherapy 11/2020
1	Activities of Daily Living (ADL) 10/2017
1	Blood Transfusion (Blood Transfusions) 04/2012